名家访谈
|
如何治疗他莫昔芬耐药的乳腺癌
他莫昔芬是ER阳性绝经前乳腺癌的一线治疗药物。但是在许多患者中会出现他莫昔芬耐药。如何治疗他莫昔芬耐药的乳腺癌取决于患者的绝经状态,他莫昔芬耐药的绝经后患者可用芳香化酶抑制剂或氟维司群治疗,起码会对转移性乳腺癌有些作用。当然,患者最终也会对这两种药物耐药,许多....
|
Oncology Frontier: Dr. Gradishar, what therapy is most beneficial for maintaining or improving the quality of life of metastatic breast cancer?
《....
|
Oncology Frontier: Dr. Davidson, you touched briefly on the SOFT trial in your talk today. Will you give us the take home message of the SOFT trial ....
|
Oncology Frontier: Dr. Yarnold, radiation fibrosis is one of the late effects of breast radiotherapy. Are there any biomarkers that can measure esta....
|
Oncology Frontier: Dr. Ollivotto, it may be safe to omit radiotherapy in patients with low risk of local recurrence. Do you have any useful tools of....
|
Oncology Frontier: Dr. Loibl, could you introduce some of the useful approaches to evaluate the tumor response of neoadjuvant therapies?
《肿瘤瞭望》:能....
|
Oncology Frontier: Dr. Ellis, it is reported that endocrine therapy resistant estrogen receptor positive breast cancer is the most common cause of b....
|
Oncology Frontier: Dr. Kang, thank you for joining us. You gave a presentation here, an award winning presentation on metastases, congratulations.
....
|
Oncology Frontier: Could you talk about the physical and emotional impact of breast reconstructive surgery today?
《肿瘤瞭望》:能否请您谈一下乳房再造术对乳腺癌患者....
|
Oncology Frontier: Dr. Clough, of your many specialties, oncoplastic surgery is something that is not widely known but you are an expert to speak ab....
|